Remove Pharmaceutical Companies Remove Pharmaceuticals Remove Pharmacy
article thumbnail

Pharmacognosy and Drug Patents: Unveiling Nature’s Medicinal Treasures

Drug Patent Watch

In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. The Essence of Pharmacognosy: Nature’s Pharmacy Unveiled Imagine walking through a lush rainforest, surrounded by countless plant species. What is a Drug Patent?

Drugs 97
article thumbnail

What Payer Trends Can Tell Us About Medication Adherence

H1 Blog

Among the pharmacy and therapeutics (P&T) committee members DRG surveyed, 44% would use pharma digital resources more frequently if companies made it easier to find content dedicated to formulary decision-makers. How do pharmaceutical companies work with payers?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Unlocking Access: Direct-to-Patient Cash Solutions for Pharma Manufacturers

Fierce BioTech

As a result of these challenges, there is a growing need for companies to develop strategies outside of the traditional distribution channels that provide direct-to-patient access paths to medication. Discover the value of a white-labeled pharmacy from a marketing messaging and operational perspective.

article thumbnail

How Pharma-Funded Groups Lie About Personal Drug Imports

Policy Prescription

NeedyMeds , a non-profit organization known for providing patients with help in finding pharmaceutical company-sponsored prescription assistance programs and other drug savings options, hosted a webinar about drug importation last year called “ Drug Importation: The topic everyone’s talking about.” Emphasis added).

article thumbnail

Gilead agrees to pay $97 million to settle Medicare kickbacks case

The Pharma Data

This legislation specifically outlaws pharmaceutical companies from offering anything of value to incentivise Medicare patients to buy their drugs. . Eleven other drug companies have settled similar cases with the government including Pfizer and Novartis, and four foundations and a pharmacy have also settled. .

article thumbnail

Abarca Details First Value-Based Agreement For Medicaid Members Prescribed Biogen Products

The Pharma Data

20, 2020 /PRNewswire/ — Abarca , a pharmacy benefit manager (PBM) that is disrupting the industry with a new approach to technology and business practices released a new case study detailing a value-based agreement with Biogen Inc. It started by redefining pharmacy benefits, but this is just the beginning.

article thumbnail

Massive Bio Launches Industry’s First NASA-Style, Oncology Clinical Trial Command Center to Disrupt and Accelerate Trial Enrollment, Featuring 72-Hour Instant Enrollment from Time of Patient Identification

The Pharma Data

Akin to the NASA Deep Space Network, SYNERGY-AI OCTCC is a real time data and communication network between patients, sites, and pharmaceutical companies, with the Massive Bio AI-enabled engine orchestrating these stakeholders for successful operations. NEW YORK–( BUSINESS WIRE )– Massive Bio, Inc. , 75N91020C00016.